Reply to: "Letter to the Editor: Cocaine use and cocaine use disorder- Revisiting epidemiology and clinical impact"

被引：0
|
作者：
Vigna-Taglianti, F. D. [1 ,2 ]
Berchialla, P. [1 ]
Nibbio, G. [3 ]
Mangiapane, C. [4 ]
Colombi, N. [5 ]
Oliva, F. [1 ]
机构：
[1] Univ Torino, Dept Clin & Biol Sci, Reg Gonzole 10, I-10043 Turin, Italy
[2] ASL TO3, Piedmont Ctr Drug Addict Epidemiol, Turin, Italy
[3] Brescia Univ, Sch Med, Dept Psychiat, Brescia, Italy
[4] Univ Torino, Dept Neurosci Rita Levi Montalcini, Turin, Italy
[5] Univ Torino, Federated Lib Med F Rossi, Turin, Italy
来源：
JOURNAL OF PSYCHIATRIC RESEARCH | 2021年 / 143卷
关键词：
ADHD; Adult; Cocaine use; Cocaine use disorder; Systematic review; Meta-analysis; BIAS;
D O I：
10.1016/j.jpsychires.2021.05.075
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：469 / 470
页数：2
相关论文
共 50 条
  • [31] Use of antipsychotics to treat cocaine toxicity? Reply
    Heard, Kennon
    Cleveland, Nathan R.
    Krier, Shay
    ACADEMIC EMERGENCY MEDICINE, 2008, 15 (01) : 106 - 106
  • [32] Cocaine use and acute coronary syndromes - Reply
    Singer, DRJ
    Swift, P
    Missouris, CG
    LANCET, 2001, 358 (9290): : 1367 - 1368
  • [33] Cocaine Withdrawal Symptoms Predict Response to Topiramate in Patients With Cocaine Use Disorder
    Kampman, Kyle
    Tamminga, Mila
    Lynch, Kevin
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 361 - 362
  • [34] ILLICIT COCAINE USE IN CLINICAL PERSPECTIVE
    YOUNG, TJ
    INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY, 1987, 31 (02) : 179 - 187
  • [35] Ibrutinib as a potential therapeutic for cocaine use disorder
    Spencer B. Huggett
    Jeffrey S. Hatfield
    Joshua D. Walters
    John E. McGeary
    Justine W. Welsh
    Trudy F. C. Mackay
    Robert R. H. Anholt
    Rohan H. C. Palmer
    Translational Psychiatry, 11
  • [36] EPIGENETICS OF COCAINE USE DISORDER IN SOUTHERN BRAZIL
    Walss-Bass, Consuelo
    Fries, Gabriel
    Viola, Thiago
    Stertz, Laura
    Grevet, Eugenio H.
    Bau, Claiton
    Rovaris, Diego Luiz
    Zhao, Zhongming
    Schmitz, Joy
    Grassi-Oliveira, Rodrigo
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 51 : E17 - E17
  • [37] INDIVIDUAL NEUROAFFECTIVE PROFILES IN COCAINE USE DISORDER
    Soder, Heather
    Kessler, Danielle
    Mckay, Sarah
    Wardle, Margaret
    Suchting, Robert
    de Dios, Constanza
    Green, Charles
    Lane, Scott
    Schmitz, Joy
    Versace, Francesco
    PSYCHOPHYSIOLOGY, 2020, 57 : S67 - S67
  • [38] Agonist Medications for the Treatment of Cocaine Use Disorder
    S Stevens Negus
    Jack Henningfield
    Neuropsychopharmacology, 2015, 40 : 1815 - 1825
  • [39] Ibrutinib as a potential therapeutic for cocaine use disorder
    Huggett, Spencer B.
    Hatfield, Jeffrey S.
    Walters, Joshua D.
    McGeary, John E.
    Welsh, Justine W.
    Mackay, Trudy F. C.
    Anholt, Robert R. H.
    Palmer, Rohan H. C.
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [40] Glutamatergic Agents for the Treatment of Cocaine Use Disorder
    Hadizadeh, Hasti
    Flores, Jose M.
    Mayerson, Talia
    Worhunsky, Patrick D.
    Potenza, Marc N.
    Angarita, Gustavo A.
    CURRENT BEHAVIORAL NEUROSCIENCE REPORTS, 2022, 9 (04) : 101 - 112
12345